Julius Knowles Net Worth & Insider Trades

Julius Knowles - Director, Keros Therapeutics, Inc

As of June 3, 2022

What is Julius Knowles's Net Worth?

The current estimated net worth of Keros Therapeutics, Inc's Director, Julius Knowles, is estimated to be about $43.84M . Julius Knowles owns about 232,727 units of Keros Therapeutics, Inc common stock. In the last 2 years at Keros Therapeutics, Inc, Julius Knowles has sold an estimated value of $28.76M worth.

What is Julius Knowles's Past Insider Trading?

Julius Knowles's largest sale order was 95,302 units , worth over $3.92M on September 29, 2021. In total, Julius Knowles has made about 20 transactions over 2 years of their time at Keros Therapeutics, Inc. Julius Knowles usually trades in June, with the busiest year in 2021. The most recent transaction was a sale order of 47,651 units , worth over $2.76M on January 5, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Julius Knowles's' Mailing Address?

  • Mailing address is C/o Keros Therapeutics, Inc. 99 Hayden Avenue, Suite 120, Building E Lexington MA 02421 MA

Keros Therapeutics, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Jasbir Seehra, Ph.D. 2020 $521,014 $8,713,137 $262,650 $3,498 $9,500,299
Jasbir Seehra, Ph.D. 2019 $485,100 $15,379 $194,040 - $694,519
Keith Regnante 2020 $323,170 $1,901,352 $138,000 $521 $2,363,042
Jennifer Lachey, Ph.D. 2020 $370,196 $3,017,362 $154,200 $521 $3,542,278
Jennifer Lachey, Ph.D. 2019 $294,255 $27,039 $93,000 - $414,294
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1664710/000110465921051967/tm2112429-1_def14a.htm

What are Keros Therapeutics, Inc's Past Insider Trades?

Keros Therapeutics, Inc's most recent insider trade came on July 19, 2022 by Jennifer Lachey who sold 46,034 units worth $1.38M . In the last 2 years, insiders at Keros Therapeutics, Inc have sold an estimated value of $35.47M and bought an estimated value of $46.26M worth of shares. Insider trading is most common in April, with the busiest year in 2021. The most active traders at the company are Jennifer Lachey, Chief Scientific Officer,  Julius Knowles, Director,  and Claudia Ordonez, Chief Medical Officer .

Keros Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1